OBJECTIVE: The fetal inflammatory response syndrome is a multisystem disord
er associated with impending preterm delivery and adverse neonatal outcome.
Inflammation of the umbilical cord-funisitis-is the histologic counterpart
of fetal inflammatory response syndrome and has been associated with an in
creased risk for the development of cerebral palsy. Neutrophils found in th
e amniotic cavity are of fetal origin. Therefore, neutrophil secretory prod
ucts may be an index of the fetal inflammatory response syndrome. To test t
his hypothesis, we examined the relationship between levels of amniotic flu
id matrix metalloproteinase-8 and funisitis.
STUDY DESIGN: The relationship between the presence of funisitis and concen
trations of amniotic fluid matrix metalloproteinase-8 was examined in 255 c
onsecutive patients who delivered preterm singleton neonates (gestational a
ge, < 36 weeks) within 72 hours of amniocentesis. Amniotic fluid was cultur
ed for aerobic and anaerobic bacteria and for mycoplasmas. Funisitis was di
agnosed in the presence of neutrophil infiltration into the umbilical vesse
l walls or Wharton jelly. Matrix metalloproteinase-8 was measured by use of
a specific immunoassay. Nonparametric statistics were used for analysis.
RESULTS: Funisitis was present in 23% (59/255) of cases. Patients with funi
sitis had a significantly higher median concentration of amniotic fluid mat
rix metalloproteinase-8 than those without funisitis (median, 433.7 ng/mL [
range, 1.5-3836.8 ng/mL] vs median, 1.9 ng/mL [range, <0.3-4202.7 ng/mL]; P
< .001). The diagnostic indices of matrix metalloproteinase-8 (cutoff, 23
ng/mL) in the identification of funisitis were: sensitivity of 90% (53/59),
specificity of 78% (153/196), positive predictive value of 55% (53/96), an
d negative predictive value of 96% (153/159).
CONCLUSIONS: There is a strong association between increased levels of amni
otic fluid matrix metalloproteinase-8 and funisitis. We propose that determ
ination of amniotic fluid matrix metalloproteinase-8 concentrations may ass
ist the assessment of the fetal inflammatory status, thereby eliminating th
e need for fetal blood sampling.